ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 181 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,099 | -44.1% | 546 | +7.1% | 0.00% | – |
| Q2 2023 | $10,914 | +155814.3% | 510 | +188.1% | 0.00% | – |
| Q1 2023 | $7 | -83.7% | 177 | -80.9% | 0.00% | – |
| Q4 2022 | $43 | -99.9% | 927 | -1.0% | 0.00% | – |
| Q3 2022 | $42,000 | -26.3% | 936 | -22.5% | 0.00% | – |
| Q2 2022 | $57,000 | +72.7% | 1,207 | +164.1% | 0.00% | – |
| Q1 2022 | $33,000 | -63.7% | 457 | -70.2% | 0.00% | -100.0% |
| Q4 2021 | $91,000 | -63.7% | 1,534 | -65.3% | 0.00% | -50.0% |
| Q3 2021 | $251,000 | -11.3% | 4,420 | -31.3% | 0.00% | 0.0% |
| Q2 2021 | $283,000 | -10.7% | 6,434 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $317,000 | +17.0% | 6,434 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $271,000 | +61.3% | 6,434 | +75.2% | 0.00% | +100.0% |
| Q3 2020 | $168,000 | +425.0% | 3,672 | +473.8% | 0.00% | – |
| Q2 2020 | $32,000 | +357.1% | 640 | +357.1% | 0.00% | – |
| Q1 2020 | $7,000 | +16.7% | 140 | +55.6% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 90 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -37.5% | 90 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -11.1% | 90 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +50.0% | 90 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -25.0% | 90 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | – | 90 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |